Clinical and genomic characterization of recurrent enterococcal bloodstream infection in patients with acute leukemia

Julia A. Messina*, Rohita Sinha, Kimberly Starr, Mehreen Arshad, Barbara D. Alexander, Nelson J. Chao, Anthony D. Sung

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Background. Rates and risk factors for recurrent enterococcal bloodstream infection (R-EBSI) and whether the same genetic lineage causes index EBSI and R-EBSI are unknown in patients with acute leukemia (AL) receiving chemotherapy. Methods. Ninety-two AL patients with EBSI from 2010 to 2015 were included. Enterococcal bloodstream infection was defined by 31 positive blood cultures for Enterococcus faecium or Enterococcus faecalis and fever, hypotension, or chills. Clearance was defined by 31 negative cultures 324 hours after last positive culture and defervescence. Recurrent enterococcal bloodstream infection was defined by a positive blood culture for Enterococcus 324 hours after clearance. Categorical variables were reported as proportions and compared by the χ2 test. Continuous variables were summarized by median and interquartile range (IQR) and compared by the Wilcoxon-Mann-Whitney Test. P values <.05 were considered significant. Whole-genome sequencing was performed on available paired BSI isolates from 7 patients. Results. Twenty-four patients (26%) had 31 episodes of R-EBSI. Median time to R-EBSI (IQR) was 26 (13-50) days. Patients with R-EBSI had significantly longer durations of fever and metronidazole exposure during their index EBSI. Thirty-nine percent of E. faecium R-EBSI isolates became daptomycin-nonsusceptible Enterococcus (DNSE) following daptomycin therapy for index EBSI. Whole-genome sequencing analysis confirmed high probability of genetic relatedness of index EBSI and R-EBSI isolates for 4/7 patients. Conclusions. Recurrent enterococcal bloodstream infection and DNSE are common in patients with AL and tend to occur within the first 30 days of index EBSI. Duration of fever and metronidazole exposure may be useful in determining risk for R-EBSI. Whole-genome sequencing analysis demonstrates that the same strain causes both EBSI and R-EBSI in some patients.

Original languageEnglish (US)
JournalOpen Forum Infectious Diseases
Volume5
Issue number6
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Leukemia
Infection
Daptomycin
Enterococcus
Enterococcus faecium
Fever
Metronidazole
Genome
Chills
Enterococcus faecalis
Hypotension
Drug Therapy

Keywords

  • Acute leukemia
  • Daptomycin-nonsusceptible Enterococcus
  • Enterococcus
  • Recurrent bloodstream infection
  • Whole-genome sequencing

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Cite this

Messina, Julia A. ; Sinha, Rohita ; Starr, Kimberly ; Arshad, Mehreen ; Alexander, Barbara D. ; Chao, Nelson J. ; Sung, Anthony D. / Clinical and genomic characterization of recurrent enterococcal bloodstream infection in patients with acute leukemia. In: Open Forum Infectious Diseases. 2018 ; Vol. 5, No. 6.
@article{5ed7b17a5ba046fa9e68b5bab1cc1a2f,
title = "Clinical and genomic characterization of recurrent enterococcal bloodstream infection in patients with acute leukemia",
abstract = "Background. Rates and risk factors for recurrent enterococcal bloodstream infection (R-EBSI) and whether the same genetic lineage causes index EBSI and R-EBSI are unknown in patients with acute leukemia (AL) receiving chemotherapy. Methods. Ninety-two AL patients with EBSI from 2010 to 2015 were included. Enterococcal bloodstream infection was defined by 31 positive blood cultures for Enterococcus faecium or Enterococcus faecalis and fever, hypotension, or chills. Clearance was defined by 31 negative cultures 324 hours after last positive culture and defervescence. Recurrent enterococcal bloodstream infection was defined by a positive blood culture for Enterococcus 324 hours after clearance. Categorical variables were reported as proportions and compared by the χ2 test. Continuous variables were summarized by median and interquartile range (IQR) and compared by the Wilcoxon-Mann-Whitney Test. P values <.05 were considered significant. Whole-genome sequencing was performed on available paired BSI isolates from 7 patients. Results. Twenty-four patients (26{\%}) had 31 episodes of R-EBSI. Median time to R-EBSI (IQR) was 26 (13-50) days. Patients with R-EBSI had significantly longer durations of fever and metronidazole exposure during their index EBSI. Thirty-nine percent of E. faecium R-EBSI isolates became daptomycin-nonsusceptible Enterococcus (DNSE) following daptomycin therapy for index EBSI. Whole-genome sequencing analysis confirmed high probability of genetic relatedness of index EBSI and R-EBSI isolates for 4/7 patients. Conclusions. Recurrent enterococcal bloodstream infection and DNSE are common in patients with AL and tend to occur within the first 30 days of index EBSI. Duration of fever and metronidazole exposure may be useful in determining risk for R-EBSI. Whole-genome sequencing analysis demonstrates that the same strain causes both EBSI and R-EBSI in some patients.",
keywords = "Acute leukemia, Daptomycin-nonsusceptible Enterococcus, Enterococcus, Recurrent bloodstream infection, Whole-genome sequencing",
author = "Messina, {Julia A.} and Rohita Sinha and Kimberly Starr and Mehreen Arshad and Alexander, {Barbara D.} and Chao, {Nelson J.} and Sung, {Anthony D.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/ofid/ofy107",
language = "English (US)",
volume = "5",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "6",

}

Clinical and genomic characterization of recurrent enterococcal bloodstream infection in patients with acute leukemia. / Messina, Julia A.; Sinha, Rohita; Starr, Kimberly; Arshad, Mehreen; Alexander, Barbara D.; Chao, Nelson J.; Sung, Anthony D.

In: Open Forum Infectious Diseases, Vol. 5, No. 6, 01.01.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and genomic characterization of recurrent enterococcal bloodstream infection in patients with acute leukemia

AU - Messina, Julia A.

AU - Sinha, Rohita

AU - Starr, Kimberly

AU - Arshad, Mehreen

AU - Alexander, Barbara D.

AU - Chao, Nelson J.

AU - Sung, Anthony D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background. Rates and risk factors for recurrent enterococcal bloodstream infection (R-EBSI) and whether the same genetic lineage causes index EBSI and R-EBSI are unknown in patients with acute leukemia (AL) receiving chemotherapy. Methods. Ninety-two AL patients with EBSI from 2010 to 2015 were included. Enterococcal bloodstream infection was defined by 31 positive blood cultures for Enterococcus faecium or Enterococcus faecalis and fever, hypotension, or chills. Clearance was defined by 31 negative cultures 324 hours after last positive culture and defervescence. Recurrent enterococcal bloodstream infection was defined by a positive blood culture for Enterococcus 324 hours after clearance. Categorical variables were reported as proportions and compared by the χ2 test. Continuous variables were summarized by median and interquartile range (IQR) and compared by the Wilcoxon-Mann-Whitney Test. P values <.05 were considered significant. Whole-genome sequencing was performed on available paired BSI isolates from 7 patients. Results. Twenty-four patients (26%) had 31 episodes of R-EBSI. Median time to R-EBSI (IQR) was 26 (13-50) days. Patients with R-EBSI had significantly longer durations of fever and metronidazole exposure during their index EBSI. Thirty-nine percent of E. faecium R-EBSI isolates became daptomycin-nonsusceptible Enterococcus (DNSE) following daptomycin therapy for index EBSI. Whole-genome sequencing analysis confirmed high probability of genetic relatedness of index EBSI and R-EBSI isolates for 4/7 patients. Conclusions. Recurrent enterococcal bloodstream infection and DNSE are common in patients with AL and tend to occur within the first 30 days of index EBSI. Duration of fever and metronidazole exposure may be useful in determining risk for R-EBSI. Whole-genome sequencing analysis demonstrates that the same strain causes both EBSI and R-EBSI in some patients.

AB - Background. Rates and risk factors for recurrent enterococcal bloodstream infection (R-EBSI) and whether the same genetic lineage causes index EBSI and R-EBSI are unknown in patients with acute leukemia (AL) receiving chemotherapy. Methods. Ninety-two AL patients with EBSI from 2010 to 2015 were included. Enterococcal bloodstream infection was defined by 31 positive blood cultures for Enterococcus faecium or Enterococcus faecalis and fever, hypotension, or chills. Clearance was defined by 31 negative cultures 324 hours after last positive culture and defervescence. Recurrent enterococcal bloodstream infection was defined by a positive blood culture for Enterococcus 324 hours after clearance. Categorical variables were reported as proportions and compared by the χ2 test. Continuous variables were summarized by median and interquartile range (IQR) and compared by the Wilcoxon-Mann-Whitney Test. P values <.05 were considered significant. Whole-genome sequencing was performed on available paired BSI isolates from 7 patients. Results. Twenty-four patients (26%) had 31 episodes of R-EBSI. Median time to R-EBSI (IQR) was 26 (13-50) days. Patients with R-EBSI had significantly longer durations of fever and metronidazole exposure during their index EBSI. Thirty-nine percent of E. faecium R-EBSI isolates became daptomycin-nonsusceptible Enterococcus (DNSE) following daptomycin therapy for index EBSI. Whole-genome sequencing analysis confirmed high probability of genetic relatedness of index EBSI and R-EBSI isolates for 4/7 patients. Conclusions. Recurrent enterococcal bloodstream infection and DNSE are common in patients with AL and tend to occur within the first 30 days of index EBSI. Duration of fever and metronidazole exposure may be useful in determining risk for R-EBSI. Whole-genome sequencing analysis demonstrates that the same strain causes both EBSI and R-EBSI in some patients.

KW - Acute leukemia

KW - Daptomycin-nonsusceptible Enterococcus

KW - Enterococcus

KW - Recurrent bloodstream infection

KW - Whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85068048481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068048481&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofy107

DO - 10.1093/ofid/ofy107

M3 - Article

C2 - 29977964

AN - SCOPUS:85068048481

VL - 5

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

SN - 2328-8957

IS - 6

ER -